Keyword: Capsugel


Tools to Meet the Challenge of Complex Protein Expression

Join us to learn how recent enhancements to protein expression platforms can significantly increase expression levels for complex proteins. New technologies for simplifying and increasing expression levels of multi-chain and complex proteins will be presented.

Lonza bulks up with $5.5B deal for Capsugel

Swiss CDMO Lonza has pulled the trigger on a $5.5 billion deal to acquire the U.S.-based contract capsule and drug producer Capsugel to create another sizable force in contract manufacturing.